Health Care & Life Sciences » Biotechnology | Immuno-Biological Laboratories Co. Ltd.

Immuno-Biological Laboratories Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,195
1,284
974
2,574
2,510
Total Accounts Receivable
178
249
220
193
203
Inventories
282
267
274
272
278
Other Current Assets
32
26
18
89
7
Total Current Assets
1,688
1,826
1,485
3,129
2,998
Net Property, Plant & Equipment
982
936
1,574
123
122
Total Investments and Advances
213
121
55
108
105
Intangible Assets
220
192
178
-
-
Other Assets
45
63
65
66
67
Total Assets
3,147
3,138
3,356
3,426
3,295
ST Debt & Current Portion LT Debt
147
102
80
146
156
Accounts Payable
17
5
7
1
8
Income Tax Payable
7
8
10
12
15
Other Current Liabilities
103
119
68
75
123
Total Current Liabilities
274
233
165
234
302
Long-Term Debt
77
283
403
1,848
973
Provision for Risks & Charges
1
2
2
2
2
Deferred Taxes
-
-
-
-
3
Total Liabilities
352
518
570
2,084
1,277
Common Equity (Total)
2,775
2,620
2,786
1,341
2,018
Total Shareholders' Equity
2,775
2,620
2,786
1,341
2,018
Total Equity
2,795
2,620
2,786
1,341
2,018
Liabilities & Shareholders' Equity
3,147
3,138
3,356
3,426
3,295
Accumulated Minority Interest
20
-
-
-
-

About Immuno-Biological Laboratories Co.

View Profile
Address
1091-1 Naka Aza-Higashida
Fujioka Gumma 375
Japan
Employees -
Website http://www.ibl-japan.co.jp
Updated 09/14/2018
Immuno-Biological Laboratories Co., Ltd. engages in the manufacture and sale of antibody-related reagents and pharmaceutical products. It operates through the following segments: Diagnostics and Reagents, Genetically Modified Silkworm, Testing, and Cosmetics-related. The Diagnostics and Reagents segment deals with the research and development of reagents and pharmaceutical products as well as in vitro diagnostic pharmaceuticals.